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Abstract 
 
Effective and selective chemoterapeutic and chemopreventive agent is needed to 
cure breast and cervical cancers. One of the potential natural material is mangosteen peel 
(Garcinia mangostana). In this study, we observed cytotoxic effect of ethanolic extract of 
mangosteen peel (EMP) on HeLa cells line and T47D cells line. The cytotoxic effect was 
determined using MTT assay.EMP showed cytotoxic effect on T47D cells and HeLa cells 
with IC50  values of 2.07 μg/ml and 10.58 µg/ml respectively. Molecular docking simulation 
was done to predict the molecular mechanism of active compund in mangosteen peel 
extract, α-mangostin, in NFқB pathway which is one of the potential pathway to induce 
cytotoxicity on T47D and HeLa cells. Docking was done using PLANTS software and the 
binding score between α-mangostin and proteasom is  -78,12, whereas the binding score 
between α-mangostin and IKK is -86.84. These results showed the possiblity mechanism of 
mangostin peel extract containing α-mangostin inhibits IKK activation in NFқB pathway. 
Based on this study, we conclude that mangosteen peel extract is potential to be developed 
as chemopreventive agent toward cervical and breast cancers. 
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INTRODUCTION 
 
Cancer is a group of disease 
characterized by uncontrolled growth and 
spread of abnormal cells that result in death if 
the spread is uncontrolled (ACS, 2011). 
Women have a greater potential of developing 
this disease, including cervical cancer and 
breast cancer. Based on data collected by WHO 
in 2006, incidence of breast cancer are 502,000 
and that is one of the leading causes of cancer 
death in the worldwide after lung cancer, liver, 
and colon. On the other hand, cervical cancer 
also has high incidence in the world even 
ranked first as a cause of death in women in 
Indonesia (Lewis and Merle, 2004; Aziz, 2009).  
So far, many researches reported that 
some natural compounds exhibited as negative 
regulator of oncogenes and positive regulator of 
tumor suppressor gene that has potentially to be 
used as a cytotoxic agent in cancer, such as 
mangosteen (Garcinia mangostana). Previous 
studies, as research conducted by Matsumoto 
(2005), proved that mangosteen peel extract 
inhibits the growth of DLD-1 cancer cells 
(human colorectal cancer cell model) at low 
doses of 5-20 µM. This is most likely related to 
the presence of xanthon as major compounds in 
mangosteen peel, namely α-mangostin 
(Chairungsrilerd et al., 1996). Biological 
activity of α-mangostin has been known to have 
antiproliferative and apotosis effects in liver 
cancer (Ho et al., 2002), leukemia (Matsumoto, 
2003), and colorectal cancer (Nakagawa et al., 
2007). In addition, α-mangostin also inhibit 
metastasis in PC-3 cancer cells. (Hung et al., 
2009). Therefore, further exploration is needed 
to know the potentially of mangosteen as an 
effective chemopreventive agent in breast and 
cervical cancers in women. 
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This study evaluated cytotoxic activity of 
ethanolic extract of mangosteen peel on T47D 
cells and HeLa cells. Cytotoxic activity was 
determined by MTT assay. In addition, 
molecular docking was conducted against 
several proteins associated with cells 
proliferation, such as proteasome and IKK. The 
results of this study are expected to be the basis 
for the development of mangosteen (Garcinia 
mangostana) as chemopreventive on cervical 
cancer and breast cancer. 
 
MATERIALS AND METHODS 
 
Plant Collection and Identification  
Powder of mangosteen peel (Garcinia 
mangostana) were obtained from Purworejo, 
Central Java in June 2011 and was identified. 
Powder was extracted by maceration method 
for 5 days with 70% ethanol (E.Merck, 
Darmstadt, Germany).  
 
Cells Culture  
T47D cells and HeLa cells are collection 
of Cancer Chemoprevention Research Center 
(CCRC) Faculty of Pharmacy Universitas 
Gadjah Mada obtained from Prof. Tatsuo 
Takeya (Nara Institute of Science and 
Technology (NAIST), Japan.  
 
Reagents 
DMEM (Dulbecco's Modified Eagle 
Medium) for T47D cells and HeLa cells were 
obtained from Gibco. Culture medium contains 
fetal bovine serum (FBS) 10% (v/v) (FBS 
qualified, Gibco, Invitrogen TM USA) and 
10,000 units/ml penicillin-10,000 μg/ml 
streptomycin (Gibco). Cells were harvested 
from the culture dish/flask using 0.25% Trypsin 
EDTA (Gibco, Invitrogen, Canada) to detached 
the cells. Reagent MTT {3-(4,5-dimetiltiazol-2-
yl)2,5-diphenyl tetrazolium bromide} with 
stock 5 mg/ml in phosphate buffered saline 
(working reagent was prepared by diluting the 
stock reagent 10 times with DMEM medium), 
the sample solvent DMSO (Dimethyl sulfoxide) 
(Sigma Aldrich Chemie GmBH, Steinheim, 
Germany), stopper reagent contains sodium 
dodecyl sulfate (SDS, Merck -Schuchardt, 
Dr.Th.Schuchardt & Co., D-85 662 
Hobenbrunn, Germay) 10% in 0.01 N HCl 
(Merck, Darmstadt, Germany), and Phosphate 
Buffer Saline wash solution (PBS) pH 7.4 were 
made with dissolving 0.2 g of KCl (for 
molecular biology, ≥ 99.0% HPLC pure (Sigma 
Aldrich Chemie GmBH, Steinheim, Germany); 
8 g NaCl (for molecular biology, ≥ 98% pure 
HPLC (Sigma Aldrich Chemie GmBH, 
Steinheim, Germany), 1.15 g Na2HPO4 (for 
molecular biology, ≥ 98.5% HPLC pure (Sigma 
Aldrich Chemie GmBH, Steinheim, Germany ), 
0.2 g of KH2PO4 (for molecular biology, ≥ 
98% HPLC pure (Sigma Aldrich Chemie 
GmBH, Steinheim, Germany) in 1 liter of 
distillated water.  
 
Cytotoxic Assay 
Cytotoxic assay was done using MTT [3-
4, 5-dimetiltiazol-2-yl)-2,5 difeniltetrazolium 
bromide] (Mosmann, 1983). Cells in 80% 
confluent were harvested and counted, then 
diluted with complete culture medium. The 
cells then were transferred into a 96-well plate 
with a total of 5 x 10
3
 cells/well followed by 
overnight incubation. After that, the sample was 
added to the wells at various concentrations 
with co-solvent DMSO and incubated at 37
0
C 
in a 5% CO2 incubator for 24 hours. At the ends 
of incubation, 100 µL MTT reagent with 
concentration 0.5 mg/ml in DMEM was added 
into each well. The plate then incubated at 37
0
C 
for 3 hours until formazan was formed. If 
formazan was formed, stopper SDS 10% in 
0.01N HCl was added. Plate then was wrapped 
with paper or alumunium foil and incubated in 
dark condition overnight. Absorbance was 
determined with an ELISA reader at λ 595 nm. 
 
Molecular Docking Using Software 
YASARA, Marvinsketch, and PLANTS  
Protein structure of the proteasome (PDB 
ID: 2F16) and IKK (PDB ID: 3RZF) as the 
docking target were downloaded through the 
website 
http://www.pdb.org/pdb/home/home.do. File 
structure of the target proteins that has been 
obtained then processed using YASARA 
software to set environmental conditions in 
accordance with the human physiological 
condition so that the simulation of complex 
formation between the target proteins really 
approaching original condition in the body. The 
structure of α-mangostin was drawn using 
MarvinSketch software. Protein and ligand then 
were processed using PLANTS to obtain the 
docking score. The ligand interactions with the 
protein was visualized using MOE. 
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Statistical Analysis  
Data that collected from ELISA Reader 
are absorbances of each well and converted in 
percent of cell viability. Percent of cell viability 
were calculated using the equation: 
                 
   
   
        
A = Absorbance cells treatment 
B = Absorbance control medium 
C = Absorbance control cels 
IC50 concentration were calculated by the 
concentration that causes 50% inhibition of cell 
growth (Doyle and Griffiths, 2000). Calculation 
of IC50 values were done using the linear 
regression of concentration versus cells 
viability.  
 
RESULTS AND DISCUSSION 
 
Cytotoxic Effect of EMP on T47D Cells 
MTT assay was used to evaluate the cell 
viability. The results suggested that EMP at the 
concentration of 5 µg/ml (Fig. 1B) altered the 
morphological appearance of T47D cells 
compared to control cells (Fig. 1A). Higher 
concentration of EMP (10 µg/ml) caused lower 
cell viability (Fig. 1C). 
 
  
Figure 1. Cytotoxic effect of EMP on T47D cells. T47D cells with density were treated with EMP (1-
15 µg/mL) and incubated for 24 hours. Cells viability were obtained from the conversion of 
absorbance values of formazan that formed by MTT treatment as described in the research 
procedure. Morphological appearance of control cells (A), cells treated with EMP 5 µg/mL 
(B) and 10 µg/mL (C). EMP treatment reduced cell viability with dose-dependent manner 
(D). Observation of cell morphology performed at the 24 hours using an inverted 
microscope with 100x magnification. Description:                  normal T47D cells,      cells 
that have undergone morphological changes. 
 
Based on morphological appearance and 
cells viability, EMP with concentration of 1 
µg/mL, 5 µg/mL, 10 µg/mL, and 15 µg/mL 
showed a linear correlation between 
concentration extract with toxicity effects. The 
IC50 value of EMP on T47D cells was 2.07 
µg/ml (p<0.05). 
Cytotoxic Effect of EMP on HeLa Cells 
On HeLa cells, the cytotoxic effects of 
EMP also showed dose-dependent phenomenon 
(Fig. 2). EMP performed cytotoxic effect to 
HeLa cells with IC50 value of 10.58 µg/mL. 
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Figure 2. Cytotoxic effect of EMP on HeLa cells. HeLa cells were treated wit EMP (1-25 µg/mL) and 
incubated for 24 hours. Cells viability were obtained from the conversion of absorbance 
values of formazan that formed by MTT treatment as described in the methods.  
 
Molecular Docking between α-mangostin 
with Proteasome and IKK 
Docking is a computational technique to 
predict whether a molecule (ligand) can bind to 
the receptor. Affinity was measured based on 
the energy stability of the system. The most 
stable interaction has low or negative free 
energy. 
In this study, PLANTS software used to 
perform docking simulations between α-
mangostin with several proteins. Before the 
docking simulations, target proteins was  
downloaded through www.pdb.org and 
prepared using the YASARA software. Ligands 
(compounds) which will dock to target proteins 
were prepared using MarvinSketch software. 
The results of the docking simulations between 
α-mangostin with the proteasome and IKK are 
presented in Table I and II. 
 
Table I. Docking score between α-mangostin and native ligand with proteasom 
Ligand Score 
α-mangostin -76.017 
BO2 (bortezomib) -103.736 
           RMSD = 5.3527 °A 
 
Table II. Docking score between α-mangostin and native ligand with IKK 
Ligand Score 
α-mangostin -85.7415 
C23 H24 Cl N5 O2 -95.1468 
           RMSD = 8.4398 °A 
 
Alfa-mangostin showed higher docking 
score (lower affinity) compared to proteasome’s 
native ligand (bortezomib). Bortezomib is a 
highly potent proteasome inhibitor and has been 
used widely in cancer therapy. On the contrary, 
α-mangostin was more potent to bind with IKK 
than the native ligand. Moreover, α-mangostin 
gave lower docking score with IKK rather than 
proteasome. In visualization of ligand 
interaction, the number of amino acids interact 
to change the conformational of structure ligand 
on proteosom was less than IKK. Moreover, the 
number of amino acids’ proteasome that altered 
by ligand is less than IKK (Table III). This 
result suggested that α-mangostin preferably 
interfere IKK activity than proteasome in NFқB 
pathway. 
Active compounds in mangosteen acting 
as anticancer agent is α-mangostin 
(Chairungsrilerd et al., 1996). In this study, we 
evaluated the cytotoxic activity of ethanolic 
extract of mangosteen peel (EMP) on T47D and 
HeLa cells. This extract performed cytotoxic 
activity in both cells with IC50 values less than 
100 µg/mL. Ueda et al. (2002) suggested that 
plant extract with IC50 less than 100 µg/mL is 
potential to be developed as anti-cancer agent.  
Both T47D and HeLa cells have survival 
mechanism against death signals. In HeLa cells, 
p53 level was decreased due to protein E6 
expressed by HPV. The E6 protein bind to p53 
and degrade p53 (Lane, 1992).  
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Figure 3. Visualization of Ligand Interactions between α-mangostin with residue of amino acids on 
Proteasome and IKK. Interaction between ligand and protein were visualized using MOE. 
The ligand is showed with green chain. Ligand interactions between α-mangostin with 
residue of amino acids on proteasome (A), BO2 (native ligand) with residue of amino acids 
on proteasome (B), α-mangostin with residue of amino acids on IKK (C), and 
C23H24ClN5O2 (native ligand) with residue of amino acids on IKK (D). These images 
showed residues of amino acids that has interaction with ligand and could change the 
ligand’s conformational. 
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Table III. Residues of Amino Acids interacts with ligand  
Protein 
Target 
Ligand Amino Acids Interaction Distance 
Proteasome 
(2F16) 
α-mangostin 
Ileum 100 
Tyrosine 186 
Ileum 14 
Alanine 44 
H-donor 
H-donor 
Ionic 
ionic 
2.77 
2.61 
1.62 
1.47 
BO2 
(bortezomib) 
Threonine 2 
Alanine 15 
Alanine 32 
Threonine 52 
Lysine 33 
Histidine 35 
Alanine 44 
H-donor 
H-donor 
H-donor 
H-donor 
H-acceptor 
Ionic 
Ionic 
2.15 
2.78 
1.71 
2.80 
2.54 
1.70 
1.72 
IKK (3RZF) 
α-mangostin 
Arginine 123 
Histidine 264 
Ionic 
Ionic  
1.38 
1.70 
C23H24ClN5O2 Arginine 123 H-acceptor 2.98 
 
 
Darma et al. (2010) reported that in addition to 
p53 deficiency, survival mechanisms of HeLa 
cells is also associated with the high expression 
of Bcl-2, which involving NFқB pathway. 
Whereas in T47D breast cancer cells, 
overexpression of Akt occurs and then activates 
the transcription factor NFқB that act as 
upstream for various antiapoptosis proteins, 
such as Bcl-2. Therefore, NFқB pathway 
become a potential target in this study that use 
both of cell models. 
NFқB pathway is one of the important 
pathways in the development of cancer cells 
due to its role as a transcription factor for some 
proteins, including antiapoptosis proteins like 
Bcl-2, Bcl-xl, and BFL1 (Gilmore, 2006). For 
its activation, NFқB requires several steps: 
phosphorylation of IĸB by IKK, and IĸB 
degradation by proteasome (Karin and Ben, 
2000). Excessive activation of NFқB causes 
resistance in some cancer cells (Wang et al., 
1999). Abrogation of p53, as occurs in cervical 
cancer cells, increase NFқB activation through 
TNF-alfa pathway (Weisz et al., 2007). 
Moreover, Akt, which is overexpressed in 
T47D cells, can also induce activation of NFқB 
by activating IKK first (Meng et al., 2002). 
Both in T47D and HeLa cells, NFқB 
pathway plays a central role for cell survival. 
There are two strategies to inhibit  this 
pathway: the inhibition of IKK activity or 
inhibition of IKB degradation by the 
proteasome. Based on molecular docking, the 
data showed that α-mangostin exhibited better 
affinity with IKK rather than proteasome. 
However, it still needs to be proven further by 
looking IKK activity  at the molecular level in 
vitro. In addition, the expression of anti-
apoptotic protein such as Bcl-2 should be 
reviewed to ensure that EMP can trigger 
apoptosis by decreasing the expression of 
antiapoptosis genes. Further study also needs to 
be done is to combine EMP with 
chemotherapeutic agent, leading to its potency 
to be a co-chemotherapeutic application 
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